Baiocchi et al. examined 109 stage II-III CRC patients for the expression levels of EGFR to ErbB4 and found membranous positive ErbB4 expression as an independent prognostic factor for recurrence, while other researchers did not find any significant relationship between ErbB4 expression and patients prognosis. The gene discussed is EGFR; the disease is colorectal carcinoma.